The Cancer Moonshot—a bold effort to accelerate progress in cancer research—is a once-in-a-lifetime opportunity for the cancer community and our nation to come together around a single disease that touches all of us. It aims to make more therapies available to more patients, while also improving our ability to prevent cancer and detect it at an early stage. The Cancer Moonshot has three ambitious goals: to accelerate scientific discovery in cancer, foster greater collaboration, and improve the sharing of data. By focusing on areas of cancer research that are most likely to benefit patients as a result of new investment, the Cancer Moonshot has brought together a large community of investigators and clinicians who are dedicated to expediting research to improve the lives of people with cancer and their loved ones.
Congress passed the 21st Century Cures Act in December 2016, authorizing $1.8 billion in funding for the Cancer Moonshot over 7 years. The funding must be appropriated each fiscal year (FY) over those 7 years. Congress appropriated $300 million to NCI for FY 2017, $300 million for FY 2018, $400 million for FY 2019, and $195 million for FY 2020. Although it is only at the midway point in terms of funding, the Cancer Moonshot is well on its way to producing meaningful improvements for people with cancer.
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.